Osanni Bio

San Francisco, United States

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.

$190.0M raised

Jun 2026

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Osanni Bio raised?

Osanni Bio has raised $190.0M in total funding. The most recent round was Series B. The last funding was announced in June 2026.

Who are Osanni Bio's investors?

Osanni Bio's investors include Patient Square Capital, Invus Opportunities, Retinal Degeneration Fund, Horowitz Group.

Where is Osanni Bio headquartered?

Osanni Bio is headquartered in San Francisco, United States.

What does Osanni Bio do?

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.

What stage is Osanni Bio at?

Osanni Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 23, 2026.

MLA

"Osanni Bio — Funding & Investors." VCBacked, June 23, 2026, https://www.vcbacked.co/company/osanni-bio. Accessed July 3, 2026.

APA

VCBacked. (2026). Osanni Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/osanni-bio

Wikipedia (cite web)

{{cite web |title=Osanni Bio — Funding & Investors |url=https://www.vcbacked.co/company/osanni-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 23, 2026.